Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibition of the binding function of Niemann-Pick C1 (NPC1) protein, a transmembrane protein located in late endosomes and lysosomes that mediates the export of LDL-derived cholesterol. Inhibition leads to intracellular cholesterol accumulation and is implicated in Niemann-Pick disease type C and viral infections. Targeting binding at key domains can modulate cellular lipid trafficking pathways.
Inhibition of cholesterol binding and transport by Niemann-Pick C1 protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Niemann-Pick C1 protein binding inhibition.